Skip to main content
. 2020 Apr 21;64(5):e02229-19. doi: 10.1128/AAC.02229-19

FIG 3.

FIG 3

Mean nacubactam (A) and meropenem (B) plasma concentration-time profiles after dosing with nacubactam alone or nacubactam coadministered with meropenem.